The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1000
ISSUE1000
May 9, 1997
Azelastine Nasal Spray for Allergic Rhinitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Azelastine Nasal Spray for Allergic Rhinitis
May 9, 1997 (Issue: 1000)
Azelastine hydrochloride, a histamine-H1 receptor antagonist, has been marketed as a 0.1% nasal spray (Astelin - Wallace) for treatment of seasonal allergic rhinitis. Corticosteroid and cromolyn sodium nasal sprays are also available for this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.